Search results
Results from the WOW.Com Content Network
Richard Stephen Sackler (born March 10, 1945) [1] is an American businessman and physician who was the chairman and president of Purdue Pharma, a former company best known as the developer of OxyContin, whose role in the opioid epidemic in the United States became the subject of many lawsuits and fines, filing for bankruptcy in 2019.
Prosecutors said that McKinsey provided Stamford, Conn.-based Purdue advice on measures it could take to "turbocharge" OxyContin sales. Consulting giant McKinsey to pay $650M to settle DOJ ...
The database "attributed the vast majority of the 76 billion opioid pills produced and shipped from 2006 through 2012 to three companies", one of which was SpecGx, a subsidiary of Mallinckrodt. In those years SpecGx supplied 28.9 billion oxycodone pills, more than 80 for each person in the United States, and over 2 billion pills just in Florida.
Oxycodone/paracetamol, sold under the brand name Percocet among others, [which?] is a fixed-dose combination of the opioid oxycodone with paracetamol (acetaminophen), used to treat moderate to severe pain. [1] In 2022, it was the 98th most commonly prescribed medication in the United States, with more than 6 million prescriptions. [2] [3]
McKinsey & Company consulting firm has agreed to pay $650 million to settle a federal investigation into its work to help opioids manufacturer Purdue Pharma boost the sales of the highly addictive ...
Purdue Pharma filed for bankruptcy in 2019 facing thousands of lawsuits alleging its marketing of OxyContin as a nonaddictive pain relief pill had triggered an opioid epidemic that led to more ...
In 1996, Purdue Pharma introduced OxyContin, a reformulated version of oxycodone in a slow-release form. 8-hour 2015 deposition of Richard Sackler about his family's role in the opioid crisis in the United States. [15] Heavily promoted, [16] [17] OxyContin is a key drug in the emergence of the opioid epidemic.
Photo of Dr. Mordechai Bar taken from a secret recording April 20, 2023, when he sold prescriptions for oxycodone, amphetamine and alprazolam to a drug dealer who was working with DEA agents.